OLEMA PHARMACEUTICALS

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 فبراير 2023 17:00:40 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 يناير 2023 15:30:01 بحسب Nasdaq GlobeNewswire

Olema Oncology to Present at 41st Annual J.P. Morgan Healthcare Conference

03 يناير 2023 06:00:58 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces OP-1250 Demonstrates Attractive Combinability with CDK 4/6 Inhibitor Palbociclib in Phase 1b Dose Escalation Study

07 ديسمبر 2022 14:37:49 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 ديسمبر 2022 15:30:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces Poster Presentations at the 2022 San Antonio Breast Cancer Symposium (SABCS)

21 نوفمبر 2022 08:16:07 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Third Quarter 2022 Financial Results and Provides Corporate Update

08 نوفمبر 2022 15:30:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 نوفمبر 2022 15:30:00 بحسب Nasdaq GlobeNewswire

Olema Oncology to Present at Upcoming Investor Conferences in November

01 نوفمبر 2022 07:00:02 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces Complete ER Antagonist OP-1250 Continues to Demonstrate Robust Activity in Phase 1/2 Clinical Trial

26 أكتوبر 2022 02:00:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces Upcoming Clinical Data Poster Presentation at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

12 أكتوبر 2022 06:01:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 أكتوبر 2022 15:29:00 بحسب Nasdaq GlobeNewswire

Olema Oncology to Present at H.C. Wainwright 24th Annual Global Investment Conference

06 سبتمبر 2022 15:30:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 سبتمبر 2022 16:01:48 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Second Quarter 2022 Financial Results and Provides Corporate Update

09 أغسطس 2022 15:35:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Advances OP-1250 into Phase 2 Monotherapy Expansion in Patients with ER+/HER2- Advanced Breast Cancer

09 أغسطس 2022 15:30:00 بحسب Nasdaq GlobeNewswire

Olema Oncology to Present at Canaccord Genuity 42nd Annual Growth Conference

04 أغسطس 2022 15:30:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 أغسطس 2022 15:30:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Receives FDA Fast Track Designation for OP-1250 for the Treatment of ER+ / HER2- Metastatic Breast Cancer

21 يوليو 2022 06:30:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 يوليو 2022 15:30:00 بحسب Nasdaq GlobeNewswire